Full-year 2024: Delivering Profitable Growth

The Group returned to profitable growth in 2024 and delivered on its guidance for the year. After a strong fourth quarter, the company is looking toward 2025 with confidence.

Key facts and Forecast

Financial results for 2024

  • Full-year net sales increased to € 21.2 billion (organically: +2.0%), EBITDA pre rose to € 6.1 billion (organically: +6.9%)
  • Strong fourth quarter: Net sales up 3.8% organically year-on-year, EBITDA pre organically by 19.7%
  • Stable dividend proposed: € 2.20 per share

Forecast 2025

  • Expecting profitable growth
  • Net sales of € 21.5 – 22.9 billion and EBITDA pre of € 6.1 – 6.6 billion

Overview: business performance in 2024

 

2024

(in € billion)

Change

(in %, compared to 2023)

Organic change

(in %, compared to 2023)

Group net sales

21.2

0.8

2.0

EBITDA pre

6.1

3.3

6.9

Life Science sales

8.9

−3.9

−3.3

Healthcare sales

8.5

5.0

7.0

Electronics sales

3.8

3.4

4.6

Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany Belén Garijo - Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

“We are back on a growth path with all three businesses. In 2025, we will continue to deliver profitable growth across our company. With our innovation-driven portfolio, we are ideally positioned to benefit from global macro trends.”

Belén Garijo

Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany

Conference calls for the media and analysts

Related News

View All News
  1. Press Releases

    Full-year 2024: Delivering Profitable Growth

    The Group returned to profitable growth in 2024 and delivered on its guidance for the year.

    2025/03/06

Upcoming Events

View All Events

Timo Breiner

Media Relations

Florian Schraeder

Head of Investor Relations

+49 6151 72 5271

+49 6151 72 91-5271

Annual Reports Archive

Find previous Annual Reports, Corporate Governance Reports & Statements in our archive.
Read more

Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.

Check Share Price